{"nct_id":"NCT03632291","title":"Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UB-221 as an Add-on Therapy in CSU Patients","status":"COMPLETED","status_verified_date":"2022-05","start_date":"2019-04-09","start_date_type":"ACTUAL","primary_completion_date":"2021-01-19","primary_completion_date_type":"ACTUAL","completion_date":"2021-01-19","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["UNH"]}